Join the Influenza Virus Vaccine, Inactivated group to help and get support from people like you.
Influenza Virus Vaccine, Inactivated News (Page 2)
In Good News for U.S., Flu Vaccine Working Well in South America
MONDAY, Sept. 11, 2023 – In a finding that should ease the minds of Americans ahead of another flu season, this year's vaccines have already cut the risk of hospitalization in half during the South A...
Recommendations Updated for Flu Vaccine in Children
TUESDAY, Aug. 29, 2023 – Recommendations have been updated for influenza vaccination among U.S. children for the 2023 to 2024 season, according to a policy statement and accompanying technical...
Vaccines Against Shingles, Pneumonia May Also Lower Your Alzheimer's Risk
MONDAY, Aug. 21, 2023 – Certain adult vaccines, including shingles and pneumonia shots, may also help seniors fight off Alzheimer's disease, new research reveals. Prior vaccination with the shingles...
CureVac’s Coronavirus Vaccine at the Center of a Fight for Control
CureVac, a German biopharmaceutical company, has hit the headlines after US President Trump tried to secure exclusive rights to its developmental coronavirus vaccine. The vaccine is being developed...
FDA Approves Fluzone High-Dose Quadrivalent (Influenza Vaccine) for Adults 65 Years of Age and Older
PARIS, Nov. 4, 2019 /PRNewswire/ – The U.S. Food and Drug Administration (FDA) has approved a supplemental Biologics License Application for Fluzone High-Dose Quadrivalent (Influenza Vaccine) for...
FDA Approves Use of 0.5 mL Dose of Fluzone Quadrivalent (influenza vaccine) in Children as Young as 6 Months of Age
BRIDGEWATER, N.J., Jan. 23, 2019 /PRNewswire/ – The U.S. Food and Drug Administration has approved the use of the 0.5 mL dose of Fluzone Quadrivalent (influenza vaccine) to include children age 6...
GSK Receives FDA Approval for Expanded Indication for Fluarix Quadrivalent (Influenza Vaccine) for Persons 6 Months and Older
Philadelphia, PA, January 11, 2018 – GSK [LSE/NYSE: GSK] announced today it has received approval from the US Food and Drug Administration’s (FDA) Center for Biologics Evaluation and Research e...
Seqirus Receives FDA Approval of Afluria Quadrivalent (Influenza Vaccine) for People Five Years of Age and Older in the U.S.
Cambridge, Mass — September 14, 2017 – Seqirus announced today that the U.S. Food and Drug Administration (FDA) has approved Afluria Quadrivalent (Influenza Vaccine) for use in people five years of a...
FDA Approves Flublok Quadrivalent Influenza Vaccine
MERIDEN, Conn., Oct. 11, 2016 /PRNewswire/ – Protein Sciences Corporation announced today that the FDA has approved its quadrivalent formulation of Flublok influenza vaccine. Flublok Quadrivalent...
Seqirus Receives FDA Approval for Afluria Quadrivalent (Influenza Vaccine) for People 18 Years of Age and Older
CAMBRIDGE, Mass., Aug. 29, 2016 /PRNewswire/ – Seqirus announced today that the US Food and Drug Administration (FDA) has approved Afluria Quadrivalent (Influenza Vaccine) for use in persons 18...
FDA Approves Fluad (influenza vaccine, adjuvanted) for Prevention of Seasonal Influenza
November 24, 2015 – The U.S. Food and Drug Administration today approved Fluad, the first seasonal influenza vaccine containing an adjuvant. Fluad, a trivalent vaccine produced from three influenza...
Sanofi Pasteur Announces FDA Approval Of Fluzone Intradermal Quadrivalent
SWIFTWATER, Pa., Dec. 12, 2014 /PRNewswire/ – Sanofi Pasteur, the vaccines division of Sanofi (EURONEXT: SAN and NYSE: SNY), today announced that the U.S. Food and Drug Administration (FDA) has...
New Fluzone Quadrivalent Four-Strain Influenza Vaccine from Sanofi Pasteur Now Licensed By FDA for Broad Age Range of Children and Adults
• The first and only 4-strain influenza vaccine option for patients as young as six months of age, • Helps protect children and adults against additional influenza B strain, • Newes...
FDA Approves Flublok - New Seasonal Influenza Vaccine Made Using Novel Technology
January 16, 2013 – The U.S. Food and Drug Administration today announced that it has approved Flublok, the first trivalent influenza vaccine made using an insect virus (baculovirus) expression...
FDA Approves GlaxoSmithKline's Fluarix Quadrivalent - Four-strain Seasonal Influenza Vaccine for Use in the U.S.
LONDON, Dec. 17, 2012 /PRNewswire/ -- GlaxoSmithKline plc [LSE/NYSE: GSK] announced today that the U.S. Food and Drug Administration (FDA) has approved FLUARIX® QUADRIVALENT (Influenza Virus V...
Ask a question
To post your own question to this support group, sign in or create an account.